4//SEC Filing
BJERKHOLT ERIC 4
Accession 0001415889-25-024462
CIK 0001759425other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 8:00 PM ET
Size
8.7 KB
Accession
0001415889-25-024462
Insider Transaction Report
Form 4
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-09-12$76.01/sh−9,578$728,024→ 39,945 total - Exercise/Conversion
Common Stock
2025-09-11+18,333→ 49,523 total - Exercise/Conversion
Restricted Stock Units
2025-09-11−18,333→ 18,333 total→ Common Stock (18,333 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F3]The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001197350
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 8:00 PM ET
- Size
- 8.7 KB